Long-acting inhaler may help in early stage COPD

The inhaler medication Spiriva may help slow the progression of COPD if given in the early stages of the disease, a new study suggests.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news

Related Links:

In COPD patients, the development of tidal expiratory flow limitation (EFLT) results in intrinsic positive end-expiratory pressure (PEEPi), leading to increased work of breathing and worsening patient-ventilator interaction. An external PEEP can mitigate these consequences but how to optimize its value it is still unknown.
Source: Respiratory Medicine - Category: Respiratory Medicine Authors: Source Type: research
FRIDAY, June 21, 2019 -- Geographic patterns of chronic obstructive pulmonary disease (COPD) prevalence are similar among current smokers, former smokers, and adults who have never smoked, according to research published in the June 21 issue of the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
This study examined sociodemographic and clinical characteristics, treatment patterns, and health resource utilization among Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) to identify predictors of nebulized arformoterol treatment. Using Medicare administrative data from 2010 to 2014, beneficiaries with ≥2 COPD outpatient visits ≥30 d apart or ≥1 COPD-related hospitalization(s) (ICD-9-CM 491.xx, 492.xx, and 496) were identified. Inclusion criteria required ≥1 COPD medication claim(s) and continuous enrollment in Parts A, B, and D. Four cohorts were identified: (a) 11,887 arformoterol u...
Source: COPD: Journal of Chronic Obstructive Pulmonary Disease - Category: Respiratory Medicine Tags: COPD Source Type: research
Publication date: Available online 19 June 2019Source: Academic RadiologyAuthor(s): Brett W. Carter
Source: Academic Radiology - Category: Radiology Source Type: research
Abstract Cigarette smoking is the leading cause of chronic obstructive pulmonary disease (COPD) in the United States; however, an estimated one fourth of adults with COPD have never smoked (1). CDC analyzed state-specific Behavioral Risk Factor Surveillance System (BRFSS) data from 2017, which indicated that, overall among U.S. adults, 6.2% (age-adjusted) reported having been told by a health care professional that they had COPD. The age-adjusted prevalence of COPD was 15.2% among current cigarette smokers, 7.6% among former smokers, and 2.8% among adults who had never smoked. Higher prevalences of COPD were obser...
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Tags: MMWR Morb Mortal Wkly Rep Source Type: research
Abstract Accumulating evidence has shown that toxic metals exposure can have adverse effects on children, but the effects of blood Pb, Hg, and Cd co-exposure on pulmonary function in children remains to be clarified. This cross-sectional multicenter study was conducted in Wuxi City, China. A total of 221 healthy children free from chronic obstructive pulmonary disease were recruited. The blood samples were collected while blood Pb, Hg, and Cd levels were determined. The forced vital capacity volume (FVC) and forced expiratory volume in the 1 s (FEV1) were measured. The associations between metals concentratio...
Source: Biological Trace Element Research - Category: Biology Authors: Tags: Biol Trace Elem Res Source Type: research
Those who had high fitness levels stayed healthier and had longer lives, as well -- up to 1.5 to 2 years longer, the study found.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Conclusions: The results demonstrate acceptable safety and feasibility of TLD in patients with COPD, with improvements in adverse event rates after procedural enhancements.Respiration
Source: Respiration - Category: Respiratory Medicine Source Type: research
AstraZeneca announced that Breztri Aerosphere (budesonide/glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy to relieve symptoms of chronic obstructive pulmonary disease (COPD). This is the first global regulatory approval for Breztri Aerosphere and is the first approval by
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
Authors: Niewiński G, Graczyńska A, Morawiec S, Raszeja-Wyszomirska J, Wójcicki M, Zieniewicz K, Główczyńska R, Grąt M Abstract BACKGROUND Orthotopic liver transplantation (OLT) is the standard of care for end-stage liver disease. The Charlson Comorbidity Index (CCI) was originally created to assess the survival rate of patients with chronic diseases, although it was modified and adopted in OLT recipients as CCI-OLT. MATERIAL AND METHODS In total of 248 consecutive liver transplant recipients with viral cirrhosis in 98 (39.5%) patients were included. CCI-OLT was calculated assigning a weight of 3...
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Chronic Obstructive Pulmonary | Health | Spiriva | Study | Tiotropium